Blog

As per a report by P&S Intelligence, the clinical alarm management market generated a value of USD 3,201 million in 2022, and it will touch USD 7,013 million, advancing at a 10.30% CAGR, by 2030.

The growth in the industry is credited to the, increasing healthcare requirement, rising disease incidence, mounting elderly population, and the growing number of government initiatives in developing and developed countries for the adoption of medical alarms.

Moreover, due to the growing investment in IP-

Revenue of USD 1,406.4 million was generated in the global pyrogen test market for 2023, which is expected to grow at a compound annual growth rate of 7.3% over the period from 2024 to 2030 and reach USD 2,284.2 million. This growth of the market can be credited to the increasing acceptance of pyrogen testing within the biopharmaceutical sector.

Furthermore, the rising development in the biotechnology and pharmaceutical industries along with the increasing count of new biologics research and intr

Dear Global Risk Community member,

Now in 2023 as ESG has transitioned from a value-adding business function to a strategic imperative for companies, it is time to take drastic action to integrate your sustainability and business strategy, adhere to evolving global regulations and position your life sciences organization for future success. 

I am therefore delighted to announce that the brand-new program for the 2nd Annual ESG in Life Science Summit launching today and this year’s event will be

Pharmaceutical and life sciences companies are in the cross-hairs when it comes to third-party and supply chain risk management. With a huge reliance on third parties across almost every phase of their businesses, a range of general and specific laws and regulations to adhere to, and a surge in cyber-attackson their data assets by malicious players, it’s no wonder that companies struggle to keep up.

COVID-19 has only exacerbated challenges to the industry with business disruption, economic uncert